# Study of the Ease of Use and Correct Use of Placebo ELLIPTA® Inhaler in Subjects With Asthma

> **NCT02586506** · PHASE4 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 259 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Placebo ELLIPTA inhaler
- **OTHER:** Questionnaire

## Key facts

- **NCT ID:** NCT02586506
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10-01
- **Primary completion:** 2016-02-04
- **Final completion:** 2016-02-04
- **Target enrollment:** 259 (ACTUAL)
- **Last updated:** 2017-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02586506

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02586506, "Study of the Ease of Use and Correct Use of Placebo ELLIPTA® Inhaler in Subjects With Asthma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02586506. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*